What antibiotic is used to treat group B strep (Streptococcus agalactiae) urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Group B Streptococcus Urinary Tract Infection

For Group B Streptococcus (GBS) urinary tract infections, penicillin G or ampicillin should be used as first-line therapy, with penicillin G being preferred due to its narrower spectrum of activity and lower likelihood of selecting for resistant organisms. 1

First-Line Treatment Options

Preferred Agents:

  • Penicillin G: 5 million units IV initially, then 2.5-3.0 million units IV every 4 hours 1, 2
  • Ampicillin: 2 g IV initially, then 1 g IV every 4 hours 1

Treatment Duration:

  • Uncomplicated UTI: 7-10 days
  • Complicated UTI or pyelonephritis: 10-14 days
  • Continue treatment for at least 48-72 hours after symptom resolution 1

Alternative Options for Penicillin-Allergic Patients

For patients with non-severe penicillin allergy:

  • Cefazolin: 2 g IV initial dose, then 1 g IV every 8 hours 1

For patients with high risk of anaphylaxis:

  • Clindamycin: 900 mg IV every 8 hours (only if susceptibility testing confirms sensitivity) 1, 2
  • Vancomycin: 1 g IV every 12 hours (for clindamycin-resistant strains) 1, 3

For uncomplicated lower UTIs:

  • Nitrofurantoin: Can be effective for uncomplicated lower UTIs 1, 4

Antibiotic Resistance Considerations

All GBS isolates remain susceptible to penicillin, ampicillin, cefazolin, and vancomycin 5. However, resistance to alternative agents is increasing:

  • Clindamycin resistance: Increased from 10.5% to 15.0% 5
  • Erythromycin resistance: Increased from 15.8% to 32.8% 5

Therefore, susceptibility testing is essential when using non-beta-lactam antibiotics, particularly for penicillin-allergic patients 1.

Special Considerations

Pregnant Patients

  • Any amount of GBS in urine during pregnancy indicates heavy colonization
  • Requires both immediate treatment of the current infection and intrapartum prophylaxis during labor 1
  • Obtain urine culture after completion of treatment to confirm eradication 1
  • Intrapartum prophylaxis is required regardless of whether the patient received treatment earlier in pregnancy 1

Antibiotic Selection Rationale

Penicillin G is preferred over ampicillin because:

  • It has a narrower spectrum of antimicrobial activity
  • Less likely to select for resistant organisms 6
  • Both achieve adequate levels in the fetal circulation and amniotic fluid 2

Follow-up

  • Obtain a urine culture after completion of treatment to confirm eradication of the infection 1
  • For pregnant women, intrapartum prophylaxis is still required even if the UTI was successfully treated earlier in pregnancy 1

Common Pitfalls to Avoid

  1. Failing to perform susceptibility testing for penicillin-allergic patients
  2. Using erythromycin without susceptibility testing due to high resistance rates
  3. Not obtaining follow-up cultures to confirm eradication
  4. Forgetting intrapartum prophylaxis for pregnant women with history of GBS bacteriuria
  5. Using fluoroquinolones as first-line therapy when better alternatives exist 1

By following these evidence-based recommendations, clinicians can effectively treat GBS UTIs while minimizing the risk of treatment failure and antibiotic resistance.

References

Guideline

Management of Group B Streptococcus Urinary Tract Infections

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antibiotic resistance patterns of group B streptococcal clinical isolates.

Infectious diseases in obstetrics and gynecology, 2004

Research

Antibiotic resistance patterns in invasive group B streptococcal isolates.

Infectious diseases in obstetrics and gynecology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.